AllianceBernstein
LVACW

AllianceBernstein’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

AllianceBernstein’s Portfolio LVACW Stock Details LVACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12,347
Closed -$1K – 3319
2022
Q3 		$1K Hold
12,347
– – ﹤0.01% 3257
2022
Q2 		$1K Hold
12,347
– – ﹤0.01% 3251
2022
Q1 		$4K Buy
+12,347
New +$5K ﹤0.01% 3258

Other funds holding LVACW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

AllianceBernstein's LVACW Position: Q4 2022 in Review

AllianceBernstein sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q4 2022, closing a stake of 12,347 shares — an estimated $1K sold.

AllianceBernstein first reported a position in LVACW in Q1 2022 and held it in 3 quarters. The position peaked at $4K in Q1 2022. 33 funds tracked by Wall St. Rank hold LVACW as of Q4 2022.

  • AllianceBernstein reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q4 2022 after selling out during the quarter.
  • AllianceBernstein sold 12,347 LAVA Medtech Acquisition Corp. Warrants shares in Q4 2022, an estimated $1K.
  • AllianceBernstein first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q1 2022 and held it in 3 quarters.
  • AllianceBernstein's LAVA Medtech Acquisition Corp. Warrants position peaked at $4K in Q1 2022.
  • 33 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q4 2022.

Based on AllianceBernstein's 13F filing for Q4 2022, filed 15 Feb 2023.